Case 1: Initiating Patients on AR-Targeted Therapy in nmCRPC

Treatment recommendations for a patient with nmCRPC based on updated data from SPARTAN, PROSPER, and ARAMIS trials.

For more resources and information regarding anticancer targeted therapies:

targeted oncology,oncology,cancer,